Explore Our Publications
Congress Materials
This page includes links to select Salix- and partner-sponsored abstracts and poster presentations shared during scientific congresses.
Information about investigational uses does not imply FDA approval, safety, or efficacy for such uses. Please note that Salix does not recommend, suggest, or endorse use of its medicines in any manner that is inconsistent with FDA labeling.
This site is updated regularly. If you don't find what you’re looking for, please check back soon for a list of currently available congress materials or contact Medical Information.
RELISTOR®
(methylnaltrexone bromide) 8 mg/12 mg subcutaneous injection, 150 mg tablets
Journal Articles
This page includes links to select Salix- and partner-sponsored publications.
Information about investigational uses does not imply FDA approval, safety, or efficacy for such uses. Please note that Salix does not recommend, suggest, or endorse use of its medicines in any manner that is inconsistent with FDA labeling.
This site is updated regularly. If you don’t find what you’re looking for, please check back soon for a list of currently available congress materials or contact Medical Information.
RELISTOR®
(methylnaltrexone bromide) 8 mg/12 mg subcutaneous injection, 150 mg tablets